CIK 0001661053 · Non-accelerated filer<br>Smaller reporting company
enVVeno Medical Corp
Sign in to watch- Ticker
- NVNO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330936180
- Phone
- 949-261-2900
- Business address
- 70 DOPPLER, IRVINE, CA, 92618
- Former names
- Hancock Jaffe Laboratories, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $123
- in 1 filing, $123 under 10b5-1 plans
Net −$123. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-11 | Duhay Francis Director | Sale 10b5-1 | −11 | $11.21 | $123 | 2,351 |
| 2026-06-11 | Duhay Francis Director | Sale 10b5-1 | −140 | $10.31 | $1K | 2,362 |
| 2026-03-12 | Duhay Francis Director | Sale 10b5-1 | −140 | $11.52 | $2K | 2,502 |
| 2025-12-16 | BERMAN ROBERT ANDREW Chief Executive Officer | Other disposition · Restricted Stock Units | −200,000 | 0 | ||
| 2025-12-16 | Alavi Hamed Chief Technology Officer | Other disposition · Restricted Stock Units | −50,000 | 0 | ||
| 2025-12-16 | Glickman Marc H. SVP & Chief Medical Officer | Other disposition · Restricted Stock Units | −100,000 | 0 | ||
| 2025-12-11 | Duhay Francis Director | Grant or award · Stock Options | +135,883 | 135,883 | ||
| 2025-12-11 | Gray Robert Director | Grant or award · Stock Options | +135,883 | 135,883 | ||
| 2025-12-11 | Jenusaitis Matthew Director | Grant or award · Stock Options | +135,883 | 135,883 | ||
| 2025-12-11 | Shrivastava Sanjay Director | Grant or award · Stock Options | +135,883 | 135,883 | ||
| 2025-12-11 | Duhay Francis Director | Sale 10b5-1 | −4,900 | $0.36 | $2K | 92,544 |
| 2025-09-15 | Duhay Francis Director | Sale 10b5-1 | −4,900 | $0.83 | $4K | 97,444 |
| 2025-05-19 | Bright Jennifer Chief Financial Officer | Grant or award · Stock Options | +350,000 | 350,000 | ||
| 2024-12-31 | Duhay Francis Director | Purchase | +81,433 | $3.07 | $250K | 102,344 |
| 2024-12-31 | Gray Robert Director | Purchase | +3,500 | $2.94 | $10K | 11,155 |
| 2024-12-24 | Shrivastava Sanjay Director | Purchase | +5,400 | $2.90 | $16K | 9,288 |
| 2024-12-19 | Jenusaitis Matthew Director | Purchase | +9,620 | $2.53 | $24K | 16,545 |
| 2024-12-19 | BERMAN ROBERT ANDREW Chief Executive Officer | Purchase | +12,000 | $2.55 | $31K | 222,236 |
| 2024-12-18 | Shrivastava Sanjay Director | Grant or award · Stock Options | +19,752 | 19,752 | ||
| 2024-12-18 | Gray Robert Director | Grant or award · Stock Options | +19,752 | 19,752 |
Page 1 of 8 · 141 trades